BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rau KM, Huang CC, Chiu TJ, Chen YY, Lu CC, Liu CT, Pei SN, Wei YC. Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Exp Ther Med 2012;4:231-6. [PMID: 23139713 DOI: 10.3892/etm.2012.594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Martinez LM, Labovsky V, Calcagno ML, Davies KM, Garcia Rivello H, Bianchi MS, Wernicke A, Fernández Vallone VB, Chasseing NA. CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients. PLoS One 2015;10:e0121421. [PMID: 25803686 DOI: 10.1371/journal.pone.0121421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
2 Andisheh-Tadbir A, Mardani M, Pourshahidi S, Nezarati K, Bahadori P. Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis. J Clin Exp Dent 2016;8:e130-5. [PMID: 27034751 DOI: 10.4317/jced.52712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Krishna Priya S, Kumar K, Hiran KR, Bindhu MR, Nagare RP, Vijaykumar DK, Ganesan TS. Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance. Int J Clin Oncol 2017;22:107-17. [PMID: 27567920 DOI: 10.1007/s10147-016-1033-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
4 Ciocâlteu A, Pirici D, Stefanescu A, Georgescu CV, Şurlin V, Săftoiu A. Endomicroscopy with Fluorescent CD105 Antibodies for "In Vivo" Imaging of Colorectal Cancer Angiogenesis. Curr Health Sci J 2015;41:288-92. [PMID: 30538832 DOI: 10.12865/CHSJ.41.03.17] [Reference Citation Analysis]
5 Martinez LM, Labovsky V, Calcagno Mde L, Davies KM, Rivello HG, Wernicke A, Calvo JC, Chasseing NA. Comparative prognostic relevance of breast intra-tumoral microvessel density evaluated by CD105 and CD146: A pilot study of 42 cases. Pathol Res Pract 2016;212:350-5. [PMID: 26872535 DOI: 10.1016/j.prp.2016.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Krishnapriya S, Malipatil B, Surekha S, Sundersingh S, Sridevi V, Ananthi B, Selvaluxmy G, Ganesan TS. Microvessel Density (MVD) in Locally Advanced Breast Cancer. Asian Pac J Cancer Prev 2019;20:1537-45. [PMID: 31128060 DOI: 10.31557/APJCP.2019.20.5.1537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ćavar S, Jelašić D, Seiwerth S, Milošević M, Hutinec Z, Mišić M. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma. Pediatr Blood Cancer 2015;62:770-5. [PMID: 25683142 DOI: 10.1002/pbc.25427] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Zhang C, Liu Y, Guo S, Zhang J. Different Biomarkers in Non-Small Cell Lung Cancer in Blood Vessel Invasion. Cell Biochem Biophys 2014;70:777-84. [DOI: 10.1007/s12013-014-9981-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wang X, Yan M, Wang Q, Wang H, Wang Z, Zhao J, Li J, Zhang Z. In Vitro DNA-Binding, Anti-Oxidant and Anticancer Activity of Indole-2-Carboxylic Acid Dinuclear Copper(II) Complexes. Molecules 2017;22:E171. [PMID: 28117677 DOI: 10.3390/molecules22010171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bauman TM, Huang W, Lee MH, Abel EJ. Neovascularity as a prognostic marker in renal cell carcinoma. Hum Pathol 2016;57:98-105. [PMID: 27436827 DOI: 10.1016/j.humpath.2016.07.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Zhang J, Zhang L, Lin Q, Ren W, Xu G. Prognostic value of endoglin-assessed microvessel density in cancer patients: a systematic review and meta-analysis. Oncotarget 2018;9:7660-71. [PMID: 29484142 DOI: 10.18632/oncotarget.23546] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
12 Rau KM, Su YL, Li SH, Hsieh MC, Wu SC, Chou FF, Chiu TJ, Chen YH, Liu CT. High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol Med Rep 2017;16:7185-90. [PMID: 28944897 DOI: 10.3892/mmr.2017.7555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
13 Trédan O, Lacroix-Triki M, Guiu S, Mouret-Reynier MA, Barrière J, Bidard FC, Braccini AL, Mir O, Villanueva C, Barthélémy P. Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model. Target Oncol 2015;10:189-98. [PMID: 25185646 DOI: 10.1007/s11523-014-0334-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
14 Zhang S, Gong M, Zhang D, Yang H, Gao F, Zou L. Thiol-PEG-carboxyl-stabilized Fe₂O ₃/Au nanoparticles targeted to CD105: synthesis, characterization and application in MR imaging of tumor angiogenesis. Eur J Radiol 2014;83:1190-8. [PMID: 24832501 DOI: 10.1016/j.ejrad.2014.03.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wei W, Li Y, Lv S, Zhang C, Tian Y. PARP-1 may be involved in angiogenesis in epithelial ovarian cancer. Oncol Lett 2016;12:4561-7. [PMID: 28101214 DOI: 10.3892/ol.2016.5226] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
16 Le Guellec S, Duprez-paumier R, Lacroix-triki M. Microenvironnement tumoral: La vision du pathologiste. Med Sci (Paris) 2014;30:372-7. [DOI: 10.1051/medsci/20143004009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Liang X, Li H, Coussy F, Callens C, Lerebours F. An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress? Chin J Cancer Res 2019;31:586-600. [PMID: 31564802 DOI: 10.21147/j.issn.1000-9604.2019.04.03] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]